GenoFocus Inc Capital Reinvestment Ratio
GenoFocus Inc capital reinvestment ratio. GenoFocus Inc (187420) has a Capital Reinvestment Ratio of 0.48x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩288.09 Million) in capital expenditures (₩138.88 Million). See cash generation quality of GenoFocus Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of GenoFocus Inc (2015–2025)
Capital reinvestment ratio of GenoFocus Inc from 2015 to 2025. This chart tracks GenoFocus Inc's Capital Reinvestment Ratio across 6 annual periods. See financial agility of GenoFocus Inc to measure the company's free cash flow as a share of total liabilities.
GenoFocus Inc Capital Reinvestment Ratio by Year (2015–2025)
GenoFocus Inc capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see 187420 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | ₩3.50 Billion | ₩1.08 Billion | ▲ +26.1% |
| 2024 | 0.24x | ₩2.87 Billion | ₩699.16 Million | ▼ -94.9% |
| 2018 | 4.74x | ₩1.56 Billion | ₩7.42 Billion | ▲ +213.4% |
| 2017 | 1.51x | ₩1.36 Billion | ₩2.06 Billion | ▼ -85.7% |
| 2016 | 10.58x | ₩516.09 Million | ₩5.46 Billion | ▲ +270.9% |
| 2015 | 2.85x | ₩2.85 Billion | ₩8.14 Billion | — |